Integra Lifesciences第四季度调整后每股收益$0.97超出预期$0.86,销售额$4.4264亿低于预期$4.4515亿

财报速递02-25
Integra Lifesciences (NASDAQ:IART) 公布季度每股收益为$0.97,高于分析师普遍预期的$0.86,增幅达到12.79%。相比去年同期每股收益$0.89,本次业绩增长了8.99%。公司季度销售额为$4.4264亿,未能达到分析师预期的$4.4515亿,差距为0.56%。然而,这一销售额相比去年同期的$3.9704亿增长了11.49%。

以上内容来自Benzinga Earnings专栏,原文如下:

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.86 by 12.79 percent. This is a 8.99 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $442.64 million which missed the analyst consensus estimate of $445.15 million by 0.56 percent. This is a 11.49 percent increase over sales of $397.04 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法